trending Market Intelligence /marketintelligence/en/news-insights/trending/QUOFOT1GMLrVPEpxiZBZkg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Argus initiates coverage of Zions at 'buy'

StreetTalk – Episode 69: Banks left with pockets full of cash and few places to go

Street Talk – Episode 69: Banks left with pockets full of cash and few places to go

Street Talk Episode 68 - As many investors zig away from bank stocks, 2 vets in the space zag toward them

Street Talk Episode 66 - Community banks tap the debt markets while the getting is good

Argus initiates coverage of Zions at 'buy'


Argus Research Co. analyst Kevin Heal is now covering Salt Lake City-based Zions Bancorp NA's stock. He gave it a "buy" rating and set a price target of $51.

Heal wrote that Zions has strong capital levels and a high loan-to-deposit ratio and is also taking advantage of decreased regulatory oversight as it is no longer designated a systemically important financial institution.

The analyst expects the bank to report stronger loan growth as compared to most regional banks, supported by its focus on high-growth Western markets. The bank's net interest margins are expected to grow further as the Federal Reserve normalizes rates.

Heal gave the bank a "medium-high" financial strength rating, based on its strong capital levels and good NIM.

The analyst also expects the bank's net interest income to continue growing at 4% in 2019 due to higher interest rates.